[
  {
    "ts": "2025-11-12T11:07:11+00:00",
    "headline": "Assessing Johnson & Johnson's Value After Medtech Acquisition and 34.6% Year-to-Date Surge",
    "summary": "Wondering if Johnson & Johnson is a bargain or overpriced right now? You are not alone. Plenty of investors are questioning whether its shares offer value at today's levels. The stock has shown solid momentum lately, climbing 3.7% in the last week and 1.6% over the past month, with a striking 34.6% year-to-date run. Driving some of this share price action are developments such as the company's recent acquisition in the medtech space and expanded strategic partnerships, both of which have...",
    "url": "https://finance.yahoo.com/news/assessing-johnson-johnsons-value-medtech-110711029.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "2256e32b-7d2a-3cd3-b82a-53a3d3a59050",
      "content": {
        "id": "2256e32b-7d2a-3cd3-b82a-53a3d3a59050",
        "contentType": "STORY",
        "title": "Assessing Johnson & Johnson's Value After Medtech Acquisition and 34.6% Year-to-Date Surge",
        "description": "",
        "summary": "Wondering if Johnson & Johnson is a bargain or overpriced right now? You are not alone. Plenty of investors are questioning whether its shares offer value at today's levels. The stock has shown solid momentum lately, climbing 3.7% in the last week and 1.6% over the past month, with a striking 34.6% year-to-date run. Driving some of this share price action are developments such as the company's recent acquisition in the medtech space and expanded strategic partnerships, both of which have...",
        "pubDate": "2025-11-12T11:07:11Z",
        "displayTime": "2025-11-12T11:07:11Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/4e8319e0e61499a110aef17faa48c1a7",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/VmOStVnJjLnU3xikg4stLA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/4e8319e0e61499a110aef17faa48c1a7.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/trESudVvS0UypUeXuQ_Yww--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/4e8319e0e61499a110aef17faa48c1a7.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/assessing-johnson-johnsons-value-medtech-110711029.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/assessing-johnson-johnsons-value-medtech-110711029.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-12T11:53:00+00:00",
    "headline": "J&J's MedTech Unit Sales Improve: Will the Momentum Last?",
    "summary": "J&J's MedTech sales rose 5.6% in Q3, fueled by cardiovascular strength and strategic portfolio shifts toward high-growth markets.",
    "url": "https://finance.yahoo.com/news/j-js-medtech-unit-sales-115300526.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "ff9ee50d-fec9-335c-906f-0de78fbd22eb",
      "content": {
        "id": "ff9ee50d-fec9-335c-906f-0de78fbd22eb",
        "contentType": "STORY",
        "title": "J&J's MedTech Unit Sales Improve: Will the Momentum Last?",
        "description": "",
        "summary": "J&J's MedTech sales rose 5.6% in Q3, fueled by cardiovascular strength and strategic portfolio shifts toward high-growth markets.",
        "pubDate": "2025-11-12T11:53:00Z",
        "displayTime": "2025-11-12T11:53:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/9fbd184faf399044b3daf708db81da25",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/zOP0QBTzaiRh4w5CHkr79w--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9fbd184faf399044b3daf708db81da25.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/SocztinenBkcdmCqGzbO3w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9fbd184faf399044b3daf708db81da25.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/j-js-medtech-unit-sales-115300526.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/j-js-medtech-unit-sales-115300526.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "MDT"
            },
            {
              "symbol": "ABT"
            },
            {
              "symbol": "SYK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-12T16:01:00+00:00",
    "headline": "Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever.",
    "summary": "These companies are demonstrating their ability to deal with significant business risks.",
    "url": "https://www.fool.com/investing/2025/11/12/want-decades-of-passive-income-2-stocks-to-buy-now/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "06f86ae9-a992-3ace-ba58-31956e6be5b5",
      "content": {
        "id": "06f86ae9-a992-3ace-ba58-31956e6be5b5",
        "contentType": "STORY",
        "title": "Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever.",
        "description": "",
        "summary": "These companies are demonstrating their ability to deal with significant business risks.",
        "pubDate": "2025-11-12T16:01:00Z",
        "displayTime": "2025-11-12T16:01:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/23ca1fd22d86e9f0fa6d563f291d160e",
          "originalWidth": 1400,
          "originalHeight": 933,
          "caption": "Person shopping inside a retail store.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/fPPG1VcVX.yQHZooyHJweg--~B/aD05MzM7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/23ca1fd22d86e9f0fa6d563f291d160e.cf.webp",
              "width": 1400,
              "height": 933,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/JklE5NVW_pypG5Fbj8jUMg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/23ca1fd22d86e9f0fa6d563f291d160e.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2025/11/12/want-decades-of-passive-income-2-stocks-to-buy-now/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/want-decades-passive-income-2-160100937.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CVS"
            },
            {
              "symbol": "^SPX"
            },
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-12T15:46:06+00:00",
    "headline": "'Michael Burry Scared Me,' Says 25-Year-Old Who Bought Nvidia Dip For $101—'SOLD IT ALL!!' Over AI Bubble Fears, Now Sitting On Cash Awaiting Crash",
    "summary": "He bought Nvidia at $101, rode the AI wave to solid gains, and then dumped everything. In a post on the Stocks subreddit, a 25-year-old investor said he sold his entire portfolio—including top performers like Nvidia (NASDAQ:NVDA), Broadcom (NASDAQ:AVGO), and Alphabet (NASDAQ:GOOG, GOOGL)) —because he's convinced the market is sitting on a ticking time bomb. \"I have SOLD IT ALL because I fear that it might crash because of all the uncertainty and overvaluation,\" he wrote. Despite gaining around 1",
    "url": "https://finance.yahoo.com/news/michael-burry-scared-says-25-154606702.html",
    "source": "Benzinga",
    "provider": "yfinance",
    "raw": {
      "id": "f1af5dab-5362-3d80-bf04-01052e98fa37",
      "content": {
        "id": "f1af5dab-5362-3d80-bf04-01052e98fa37",
        "contentType": "STORY",
        "title": "'Michael Burry Scared Me,' Says 25-Year-Old Who Bought Nvidia Dip For $101—'SOLD IT ALL!!' Over AI Bubble Fears, Now Sitting On Cash Awaiting Crash",
        "description": "",
        "summary": "He bought Nvidia at $101, rode the AI wave to solid gains, and then dumped everything. In a post on the Stocks subreddit, a 25-year-old investor said he sold his entire portfolio—including top performers like Nvidia (NASDAQ:NVDA), Broadcom (NASDAQ:AVGO), and Alphabet (NASDAQ:GOOG, GOOGL)) —because he's convinced the market is sitting on a ticking time bomb. \"I have SOLD IT ALL because I fear that it might crash because of all the uncertainty and overvaluation,\" he wrote. Despite gaining around 1",
        "pubDate": "2025-11-12T15:46:06Z",
        "displayTime": "2025-11-12T15:46:06Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Benzinga/66c7244780529815c6d55546dae98528",
          "originalWidth": 1024,
          "originalHeight": 683,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/424uxAL0bdJ0KT332r4GLA--~B/aD02ODM7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Benzinga/66c7244780529815c6d55546dae98528.cf.webp",
              "width": 1024,
              "height": 683,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/AjH14Ili6pWotZuwcA1XlQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Benzinga/66c7244780529815c6d55546dae98528.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Benzinga",
          "url": "http://www.benzinga.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/michael-burry-scared-says-25-154606702.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/michael-burry-scared-says-25-154606702.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NVDA"
            },
            {
              "symbol": "GOOGL"
            },
            {
              "symbol": "INTC"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "O"
            },
            {
              "symbol": "PLTR"
            },
            {
              "symbol": "AVGO"
            },
            {
              "symbol": "TSLA"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-12T16:53:00+00:00",
    "headline": "Psoriatic Arthritis Market Trends and Competitive Analysis, 2025-2035 - Asia-Pacific and Latin America Offer New Growth Opportunities as Demand for Accessible Treatments Rises",
    "summary": "Precision medicine and next-gen biologics are transforming patient care. Despite cost-related challenges, key players like AbbVie, Johnson & Johnson, and Bristol-Myers Squibb are leading innovations.Dublin, Nov. 12, 2025 (GLOBE NEWSWIRE) -- The \"Psoriatic Arthritis Market - A Global and Regional Analysis: Focus on Drug Type and Region - Analysis and Forecast, 2025-2035\" has been added to ResearchAndMarkets.com's offering. The growing prevalence of autoimmune diseases, particularly among individu",
    "url": "https://finance.yahoo.com/news/psoriatic-arthritis-market-trends-competitive-165300394.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "e8727f83-3fa8-3e31-a17a-263dc57e15d7",
      "content": {
        "id": "e8727f83-3fa8-3e31-a17a-263dc57e15d7",
        "contentType": "STORY",
        "title": "Psoriatic Arthritis Market Trends and Competitive Analysis, 2025-2035 - Asia-Pacific and Latin America Offer New Growth Opportunities as Demand for Accessible Treatments Rises",
        "description": "",
        "summary": "Precision medicine and next-gen biologics are transforming patient care. Despite cost-related challenges, key players like AbbVie, Johnson & Johnson, and Bristol-Myers Squibb are leading innovations.Dublin, Nov. 12, 2025 (GLOBE NEWSWIRE) -- The \"Psoriatic Arthritis Market - A Global and Regional Analysis: Focus on Drug Type and Region - Analysis and Forecast, 2025-2035\" has been added to ResearchAndMarkets.com's offering. The growing prevalence of autoimmune diseases, particularly among individu",
        "pubDate": "2025-11-12T16:53:00Z",
        "displayTime": "2025-11-12T16:53:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/93d5b27580f67db722dd7c112e43e8bc",
          "originalWidth": 480,
          "originalHeight": 58,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/_MlAqEncKPaKK77zrkRGmQ--~B/aD01ODt3PTQ4MDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/93d5b27580f67db722dd7c112e43e8bc.cf.webp",
              "width": 480,
              "height": 58,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/caWFqk489OEmv3xI33JamQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/93d5b27580f67db722dd7c112e43e8bc.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/psoriatic-arthritis-market-trends-competitive-165300394.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/psoriatic-arthritis-market-trends-competitive-165300394.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-12T17:54:03+00:00",
    "headline": "BeOne, IBD Stock Of The Day, Breaks Out As It Takes On Cancer Giants J&J, AbbVie",
    "summary": "BeOne Medicines is Wednesday's IBD Stock Of The Day. The IBD 50 biotech is breaking out after a record-breaking quarter.",
    "url": "https://www.investors.com/research/ibd-stock-of-the-day/beone-medicines-breaks-out-brukinsa-sales/?src=A00220&yptr=yahoo",
    "source": "Investor's Business Daily",
    "provider": "yfinance",
    "raw": {
      "id": "48d36c78-d14d-3f59-85a2-880b0d771157",
      "content": {
        "id": "48d36c78-d14d-3f59-85a2-880b0d771157",
        "contentType": "STORY",
        "title": "BeOne, IBD Stock Of The Day, Breaks Out As It Takes On Cancer Giants J&J, AbbVie",
        "description": "",
        "summary": "BeOne Medicines is Wednesday's IBD Stock Of The Day. The IBD 50 biotech is breaking out after a record-breaking quarter.",
        "pubDate": "2025-11-12T17:54:03Z",
        "displayTime": "2025-11-12T17:54:03Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/48d36c78-d14d-3f59-85a2-880b0d771157/beone-ibd-stock-of-the-day-.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/ibd.com/f29014444e2d5c2bbb53588336afe804",
          "originalWidth": 816,
          "originalHeight": 430,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/tkdSuCB2ZJdv0hY7SXxppg--~B/aD00MzA7dz04MTY7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ibd.com/f29014444e2d5c2bbb53588336afe804.cf.webp",
              "width": 816,
              "height": 430,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/3zqQTYrwTxJyEhkPfZ7TsQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ibd.com/f29014444e2d5c2bbb53588336afe804.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Investor's Business Daily",
          "url": "http://www.investors.com/"
        },
        "canonicalUrl": {
          "url": "https://www.investors.com/research/ibd-stock-of-the-day/beone-medicines-breaks-out-brukinsa-sales/?src=A00220&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "AZN"
            },
            {
              "symbol": "AZNCF"
            },
            {
              "symbol": "BEIGF"
            },
            {
              "symbol": "ONC"
            },
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "AZN.L"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-12T16:51:00+00:00",
    "headline": "How Much Did Skyrizi and Rinvoq Drive AbbVie's Q3 Performance?",
    "summary": "ABBV's growth engine keeps humming as Skyrizi and Rinvoq together now power more than 40% of total revenues and drive new market share gains.",
    "url": "https://finance.yahoo.com/news/much-did-skyrizi-rinvoq-drive-165100259.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "31e103ac-bcca-3227-84f4-404efc3c8a3e",
      "content": {
        "id": "31e103ac-bcca-3227-84f4-404efc3c8a3e",
        "contentType": "STORY",
        "title": "How Much Did Skyrizi and Rinvoq Drive AbbVie's Q3 Performance?",
        "description": "",
        "summary": "ABBV's growth engine keeps humming as Skyrizi and Rinvoq together now power more than 40% of total revenues and drive new market share gains.",
        "pubDate": "2025-11-12T16:51:00Z",
        "displayTime": "2025-11-12T16:51:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/dbd916198e87314e1ef238f8179e6227",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/OQG3.5Wd9P9R69q2rhm9rA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/dbd916198e87314e1ef238f8179e6227.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/pBlncPVBhEXpjxtBDlEOsg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/dbd916198e87314e1ef238f8179e6227.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/much-did-skyrizi-rinvoq-drive-165100259.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/much-did-skyrizi-rinvoq-drive-165100259.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-12T17:26:00+00:00",
    "headline": "Bayer Q3 Earnings Beat Estimates on Crop Science Business Gains",
    "summary": "Bayer's Q3 earnings surged on Crop Science strength, offsetting pricing and currency headwinds across divisions.",
    "url": "https://finance.yahoo.com/news/bayer-q3-earnings-beat-estimates-172600645.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "04a90588-3571-3a29-9c95-cd5ab3ba7508",
      "content": {
        "id": "04a90588-3571-3a29-9c95-cd5ab3ba7508",
        "contentType": "STORY",
        "title": "Bayer Q3 Earnings Beat Estimates on Crop Science Business Gains",
        "description": "",
        "summary": "Bayer's Q3 earnings surged on Crop Science strength, offsetting pricing and currency headwinds across divisions.",
        "pubDate": "2025-11-12T17:26:00Z",
        "displayTime": "2025-11-12T17:26:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/50c06d1d19c16cb71d6cb49028119372",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/5pnU3NQ.800lSpcRBKjZNg--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/50c06d1d19c16cb71d6cb49028119372.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/W2_ZZ2Pl7OVNL4tXoICDoQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/50c06d1d19c16cb71d6cb49028119372.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/bayer-q3-earnings-beat-estimates-172600645.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bayer-q3-earnings-beat-estimates-172600645.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BAYN.DE"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "BAYRY"
            },
            {
              "symbol": "BAYZF"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]